[Recurrent systemic arterial embolism in patients with valve prostheses]

Area of Science:

• Cardiovascular Surgery
• Thromboembolic Disease
• Prosthetic Heart Valves

Context:

• Cardiac valve replacement is a common procedure for treating valvular heart disease.
• Systemic thrombo-embolic events (TEE) are a significant complication following prosthetic valve implantation.
• Understanding the clinical features and risk factors for recurrent TEE is crucial for patient management.

Purpose:

• To analyze the clinical features of recurrent systemic embolism in patients undergoing cardiac valve replacement.
• To identify predisposing factors for thrombo-embolic events (TEE) and their recurrence.
• To evaluate the impact of anticoagulant control on TEE recurrence rates.

Summary:

• A study of 400 patients undergoing cardiac valve replacement found a high incidence of recurrent systemic thrombo-embolic events (TEE), affecting 8.25% of patients.
• Key risk factors for TEE included mitral valve prosthesis, atrial fibrillation, left atrial dilatation, and inadequate anticoagulant control.
• Recurrent embolism often occurred at the same site, leading to severe consequences, including death or invalidating sequelae. Thrombosis was frequently observed on prosthetic valves.

Impact:

• The findings highlight the serious nature and high recurrence rate of TEE after cardiac valve replacement.
• Identifying specific risk factors allows for targeted preventive strategies and improved patient selection.
• Emphasizes the critical role of strict anticoagulant therapy adherence in reducing TEE and recurrence, potentially decreasing the need for reoperation.